document

Clinical Impact of the Alzheimer’s Disease Neuroimaging Initiative: A Review of Studies Using ADNI Data

Veitch DP Miller MJ Kanoria S Aisen PS Beckett LA Green RC Harvey DJ Jack Jr. CR Jagust W Lee EB Nho K Nosheny R Okonkwo OC Perrin RJ Petersen RC Mindt MR Saykin AJ Shaw LM Toga AW Tosun D Landau SM Weiner MW Alzheimer’s Disease Neuroimaging Initiative
Alzheimer's & Dementia: The Journal of the Alzheimer's Association In Press

Contributions of the Alzheimer’s Disease Neuroimaging Initiative to advancing AD research: A targeted review of recent publications

Veitch DP, Miller MJ, Kanorial S, Aisen PS, Beckett LA, Green RC, Harvey DJ, Jack Jr. CR, Jagust W, Lee EB, Lees EB, Nho K, Nosheny R, Okonkwol OC, Perrin RJ, Petersen RC, Mindt MR, Saykin AJ, Shaw LM, Toga AW, Tosun D, Landau SM, Weiner MW, for the Alzheimer's Disease Neuroimaging Initiative
Alzheimer's and Dementia In Press

Navigating data sharing in research

Lewis ACF, Clayton EW, Bangash H, Bland HT, Bonini KE, Cimino JJ, Connolly JJ, Freimuth RR, Fullerton SM, Hakonarson H, Holm IA, Jarvik GP, Khan A, Kiryluk K, Linder JE,Luo Y, Lynch JA, Mittendorf KF, Pacheco JA, Rasmussen LV, Rose SL, Rowley R, Sharp RR, Walunas TL, Wei WQ, Weng C, Sabatello M
American Journal of Human Genetics April 2026  

Rare Disease Day at NIH 2026: Paving the Way to a Brighter Future for All Americans

NIH National Center for Advancing Translational Sciences |
March 2026
Press

In celebration of 2026 Rare Disease Day, nearly 2,300 researchers, clinicians, patients, and advocates filled the halls of the NIH Natcher Conference Center or joined virtually to highlight the urgency and opportunity of advancing rare disease research. With more than 10,000 identified rare diseases affecting millions of Americans, speakers emphasized the need for innovative trial … Continued

Selection of genetic conditions for multi-state genomic newborn screening in BEACONS-NBS

Gold NB, Johnson BA, Somanchi H, Minten T, Coury SA, Blout Zawatsky CL, Begtrup A, Butler E, Langley KG, Zimmerman R, McLaughlin HM, Ellefson T, Kern A, Rehm HL, Bick D, Brenner SE, Kasperaviciute D, Abraham RS, Aksentijevich I, Babinski M, Billington Jr. CJ, Butte MJ, Canna SW, Caron M, Chan YM, Chandrakasan S, Chiang SCC, Delmonte OMM, Diller LR, Downie L, Fleischer J, Fulton A, Ganetzky RD, Gold J, Goldbach-Mansky R, Grunebaum E, Hale RC, Hamosh A, Hildebrandt F, Holtz AM, Jacobsen C, Kan MJ, Kitcharoensakkul M, Kodyte V, Kreienkamp RJ, Lennerz BS, Lin AE, Madduri AV, Majzoub JA, Marsh RA, Miller DT, Milner JD, Mitchell DM, Murray B, Notarangelo LD, Peng XP, Place EM, Platt CD, Plon SE, Plotkin SR, Powell CM, Puck JM, Roberts AE, Sankaran VG, Schwartz DM, Seroogy CM, Srinath S, Strong A, Sullivan KE, Tan W, Tarrant TK, Thiagarajah JR, Walker MA, Wassner AJ, Bolanos HZ, The BEACONS-NBS team, Gaviglio AM, Bonhomme N, Ojodu J, Singh S, Zarbalian G, Pereira S, Goldenberg AJ, Holm IA, Wasserstein MP, Green RC
medRxiv March 2026  

Newborn Genomic Screening Takes Center Stage at ACMG as Stakeholders Discuss Progress, Concerns

GenomeWeb |
March 2026
Press

As newborn genomic screening initiatives continue to unfold around the world, the ethical and responsible implementation of the approach into public health sparked vibrant discussions at the American College of Medical Genetics and Genomics (ACMG) annual meeting last week. In addition to updates from notable newborn genomic screening studies — such as the UK’s Generation … Continued

Genetic findings and healthcare utilization among individuals undergoing population genomic screening for actionable hereditary disorders

Ekstein T, Aguilar S, Russell EM, Ellsworth RE, Christensen KD, Hulick P, Green RC, Nussbaum R, Aradhya S, Garcia J
Genetics in Medicine In Press

BEACONS Newborn Genome Screening Study Selects Seven Sites, Finalizes Gene List

GenomeWeb |
January 2026
Press Release

GenomeWeb celebrates the BEACONS team’s announcement regarding the selection of 7 U.S. states and territories selected to assess the feasibility of integrating whole genome sequencing into public health newborn screening. The team also published the curated gene list, which consists of 746 genes associated with 777 genetic conditions, all clinically actionable within the first year … Continued

BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study

Ariadne Labs Press |
January 2026
Press Release

Ariadne Labs covers the announcement of two major milestones from the newly NIH-funded study, BEACONS. Six states and one U.S. territory have been selected to assess feasibility of integrating whole genome sequencing into public health newborn screening. The BEACONS team has also published the curated gene list, consisting of 777 genetic conditions, all actionable within … Continued

Genomic risk model to implement precision prostate cancer screening in clinical care: theProGRESS study

Vassy JL, Dornisch AM, Karunamuni R, Gatzen M, Kachulis CJ, Lennon NJ, Brunette CA, Danowski ME, Hauger RL, Garraway IP, Kibel AS, Lee KM, Lynch JA, Maxwell KN, Ratner D, Rose BS, Teerlink CC, Xu GJ, Hofherr SE, Lafferty KA, Larkin K, Malolepsza E, Patterson CJ, Toledo DM, Donovan JL, Hamdy FC, Martin RM, Neal DE, Turner EL, Andreassen OA, Dale AM, Mills IG, Abraham A, Batra J, Clements J, Cussenot O, Cybulski C, Eeles RA, Fowke JH, Grindedal EM, Grönberg H, Hamilton RJ, Lim J, Lu YJ, MacInnis RJ, Maier C, Mucci LA, Multigner L, Neuhausen SL, Nielsen SF, Parent MÉ, Park JY, Petrovics G, Plym A, Razack A, Rosenstein BS, Schleutker J, Sørensen KD, Townsend PA, Travis RC, Vega A, West CML, Wiklund F, Zheng W, Seibert TM, Profile SteeringCommittee, IMPACT Study Steering Committee and Collaborators, PRACTICAL Consortium, VA Million VeteranProgram, Seiber TM
Nature Cancer January 2026  

Nationwide genetic screening proves effective at catching disease risk early

Nature News & Views |
January 2026
Press

This Nature article highlights how nationwide genetic screening shows promise for early disease risk detection. Evidence from a large Australian pilot demonstrates population-wide genetic screening in young adults can successfully identify individuals at increased risk for serious heritable conditions, including hereditary cancers and high cholesterol, before symptoms arise. The findings outline the potential of early … Continued

Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot

Lacaze P, Tiller J, Brotchie A, Nguyen-Dumont T, Steen J, Belluccio D, Young M, Willis A, Mitchell LA, Nowak KJ, Burns B, Horton AE, Nicholls SJ, Ademi Z, Green RC, Manchanda R, Thompson BA, Thomas D, Milne RL, Bruinsma Delatycki MB, Pang J, Watts GF, Macrae F, Oiolawski N, Kirk J, Tucker K, Andrews L, Wallis M, Rusman R, Pachter N, Sullivan D, Ragunathan A, James P, Zalcberg J, McNeil JJ, Southey MC, Winship I
Nature Health January 2026  

Study: Major Gaps Block Genetics Evaluation and Testing for Black and Low Income Patients

Newswise of Perelman School of Medicine at the University of Pennsylvania |
December 2025
Press Release

This press release describes crucial findings from a joint study by the Perelman School of Medicine at the University of Pennsylvania and Massachusetts General Hospital. The research team highlights systemic obstacles in primary care, lack of referral guidelines, and workforce shortages, and they call for interventions like decision-support flags in electronic health records, embedded genetic … Continued

Explore 2025’s Most Impactful Genetics Research

Elsevier |
December 2025
Press

Join us in celebrating Nina Gold and her team’s incredible work investigating the sensitivity of genomic newborn screening for treating inherited metabolic conditions. Editor-in-Chief Robert D. Steiner of Genetics in Medicine recognized this work as one of the most impactful pieces of genetics research published in 2025!

Dr. Robert Green Speaks at TED on Bringing Preventive Genomics into Everyday Care

Ariadne Labs News |
September 2025
Press Release

Ariadne Labs celebrates Dr. Robert Green’s TED Talk, which explores how preventive genomics could transform medicine by identifying disease risk before symptoms ever appear, even from birth. Drawing on the world’s first DNA screening of healthy newborns, he makes the case for a future of care focused on prediction and prevention, not just treatment.

The Double-Edged Code: The promise and peril of personal genomics

Inside Precision Medicine |
December 2025
Press

This article explores the critical transition toward genomic implementation into precision health, examining the economic, clinical, and ethical frameworks required to integrate genomic data into everyday care. Featuring insights from G2P Director Dr. Robert Green and other leading experts, it challenges us to consider how we will responsibly navigate the most intimate information we possess.

Can Genomic Sequencing at Birth Transform Medicine? Reflections from My TED Talk

Medium |
December 2025
G2P Blog

In this blog post, Dr. Green reflects on his mainstage TED Talk, making the case that integrating whole-genome sequencing at birth could reveal thousands of treatable genetic risks early in life. Drawing on findings from BabySeq Project and the newly funded BEACONS Initiative, he shows how a single test at birth could give families actionable … Continued

APHL Convenes Newborn Whole Genome Sequencing Initiative, Ensuring Public Health Laboratory Input

APHL Blog |
December 2025
Press

APHL celebrates the launch of BEACONS, the nation’s first multi-state initiative evaluating whether whole genome sequencing (WGS) can be responsibly integrated into the U.S. newborn screening system. With a $14.4M NIH award and invaluable participation from public health labs across the country, BEACONS will test how WGS affects workflows, consent, data systems, and the actionable … Continued

The Future of Veteran Health: Dr. Jason Vassy on genomic medicine

VA News |
December 2025
Podcast

In this episode, Dr. Jason Vassy explains how genomic tools are transforming Veteran health, from tailoring medications using DNA to improving prostate cancer screening. Drawing on VA-wide research efforts like MVP and the PROGRESS Study, he shows what personalized, preventive care could look like in the years ahead.

Genetics and context for precision health in Greater Boston

Natarajan P, Koyama S, Wang Y, Paruchuri K, Uddin MM, Cho SM, Urbut S, Sui Y, Fahed A, Kamineni H, Haidermota S, Hornsby W, Green RC, Daly M, Neale B, Ellinor P, Smoller J, Slaugenhaupt S, Lebo M, Karlson E, Martin A
Nature Communications November 2025  

A Spectacular, Fashion-filled Night in Doha: Inside the Inaugural Franca Fund Gala

Vogue |
November 2025
Press

The inaugural Franca Fund Gala, held at Doha’s Museum of Islamic Art and hosted by Anna Wintour alongside Francesco Carrozzini and H.E. Sheikha Al Mayassa, celebrated the legacy of Franca Sozzani while raising over $4 million to support Dr. Robert Green’s pioneering work in preventive genomics. Proceeds from the evening directly advance the Franca Fund’s … Continued

document

Genetics and context for precision health in greater Boston

Koyama S Wang Y Paruchuri K Uddin MM Cho SMJ Urbut SM Sui Y Fahed AC Kamineni H Haidermota S Hornsby WE Green RC Daly MJ Neale BM Ellinor PT Smoller JW Slaugenhaupt SA Lebo MS Karlson EW Martin AR Natarajan P
In Press

NIH Funds Multi-State Pilot For Genome Sequencing in Newborn Screening

News Medical Net |
October 2025
Press

Dr. Green describes the impact of the novel, NIH-funded BEACONS study: “For more than 50 years, newborn screening has been a beacon of trust, saving children’s lives by analyzing a few drops of blood after birth. BEACONS brings the next generation of hope, giving families the option of genomic screening for hundreds of additional conditions … Continued

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Business Wire - Yahoo Finance |
October 2025
Press

GeneDx has launched the first multi-state national genomic newborn screening initiative, supported by a $14.4 million award from the National Institutes of Health Common Fund Venture Program. The effort, part of the BEACONS project, will enroll thousands of newborns to study how whole genome sequencing could be integrated into standard public health newborn screening systems.

The NIH Venture Program Announces First Award for the NBSxWGS (BEACONS) Initiative

NIH |
September 2025
Press

The NIH Common Fund’s Venture Program has announced the first award for the NBSxWGS (BEACONS) initiative, a multi-institutional effort to assess the feasibility of integrating whole genome sequencing into U.S. public health newborn screening programs. BEACONS brings together academic leaders, public health laboratories, sequencing partners, and community stakeholders to explore how genomic screening could identify … Continued

G2P Summer Newsletter 2025

August 2025
G2P News

What better way to lounge around, enjoying the dog days, than to catch up on G2P news? In this newsletter, G2P presents several summer reads (and a listen!), exploring the various ways genomics is shaping the future of healthcare—and what it means for all of us. Also, come join us at the 2025 Annual Meeting … Continued

The Ethical Minefield of Testing Infants for Incurable Diseases

New York Times |
June 2025
Press

When Dr. Robert C. Green began BabySeq in 2013, it was the first program in the world to sequence healthy babies, and it was “totally radioactive,” he said. Screening can determine their risk for an ever-growing list of conditions — including ones we can’t do much about.